Observational studyBreast cancer research and treatment2019

Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion.

Landry K Kamdem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.